joae glp-1 PRO, 60 Veg Capsules Scam weight-loss drops marketed to

For example, semaglutide and empagliflozin showed no significant difference in 3-point MACE (HR 1.05

The global GLP-1 market is on a significant growth trajectory, anticipated to rise from an estimated $44.5 million in 2023 to $95.4 million by 2031,...

These facts, together with increasing comorbidities in patients with IBD, imply that urgent, more complex, novel therapeutic strategies in the treatment are needed

- Platelets* (PLT)

Pushing the Boundaries of GLP-1 Innovation Hanmi to Present Six Obesity Drug Studies at ADA 2025Hanmi Pharmaceutical to Unveil Six Research Updates on HM15275 and HM17321 at ADA 2025Phase 1 Results of Next-Generation Triple Agonist HM15275 to Be Unveiled for the First Time